237 related articles for article (PubMed ID: 18472817)
1. Cancer immunotherapy: potential involvement of mediators.
Ben-Efraim S
Mediators Inflamm; 1997; 6(3):163-73. PubMed ID: 18472817
[TBL] [Abstract][Full Text] [Related]
2. Modulation of antitumour activity of macrophages by regulation of eicosanoids and cytokine production.
Ben-Efraim S; Bonta IL
Int J Immunopharmacol; 1994; 16(5-6):397-9. PubMed ID: 7927985
[TBL] [Abstract][Full Text] [Related]
3. Cooperation of liver cells in health and disease.
Kmieć Z
Adv Anat Embryol Cell Biol; 2001; 161():III-XIII, 1-151. PubMed ID: 11729749
[TBL] [Abstract][Full Text] [Related]
4. Involvement of inflammatory mediators in macrophage antitumor activity.
Bonta IL; Ben-Efraim S
J Leukoc Biol; 1993 Dec; 54(6):613-26. PubMed ID: 8245715
[TBL] [Abstract][Full Text] [Related]
5. Dendritic cells transfected with lentiviral vector-encoding human granulocyte-macrophage colony-stimulating factor augment anti-tumour T-cell response in vitro.
Cui J; Lin AL; Liu Q; Sun Q; Gao ZH
Int J Immunogenet; 2010 Oct; 37(5):329-36. PubMed ID: 20518832
[TBL] [Abstract][Full Text] [Related]
6. Granulocyte-macrophage colony-stimulating factor modulates lipopolysaccharide (LPS)-binding and LPS-response of human macrophages: inverse regulation of tumour necrosis factor-alpha and interleukin-10.
Kreutz M; Hennemann B; Ackermann U; Grage-Griebenow E; Krause SW; Andreesen R
Immunology; 1999 Dec; 98(4):491-6. PubMed ID: 10594679
[TBL] [Abstract][Full Text] [Related]
7. Interactions between rnacrophage cytokines and eicosanoids in expression of antitumour activity.
Ben-Efraim S
Mediators Inflamm; 1992; 1(5):295-308. PubMed ID: 18475475
[TBL] [Abstract][Full Text] [Related]
8. Tumour cell derived effects on monocyte/macrophage polarization and function and modulatory potential of Viscum album lipophilic extract in vitro.
Estko M; Baumgartner S; Urech K; Kunz M; Regueiro U; Heusser P; Weissenstein U
BMC Complement Altern Med; 2015 Apr; 15():130. PubMed ID: 25902944
[TBL] [Abstract][Full Text] [Related]
9. IL-4 determines eicosanoid formation in dendritic cells by down-regulation of 5-lipoxygenase and up-regulation of 15-lipoxygenase 1 expression.
Spanbroek R; Hildner M; Köhler A; Müller A; Zintl F; Kühn H; Rådmark O; Samuelsson B; Habenicht AJ
Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5152-7. PubMed ID: 11320251
[TBL] [Abstract][Full Text] [Related]
10. T-cells expressing a chimeric-PD1-Dap10-CD3zeta receptor reduce tumour burden in multiple murine syngeneic models of solid cancer.
Parriott G; Deal K; Crean S; Richardson E; Nylen E; Barber A
Immunology; 2020 Jul; 160(3):280-294. PubMed ID: 32144940
[TBL] [Abstract][Full Text] [Related]
11. Cytokines and HIV-1: interactions and clinical implications.
Kedzierska K; Crowe SM
Antivir Chem Chemother; 2001 May; 12(3):133-50. PubMed ID: 12959322
[TBL] [Abstract][Full Text] [Related]
12. Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism.
Danis VA; Millington M; Hyland VJ; Grennan D
Clin Exp Immunol; 1995 Feb; 99(2):303-10. PubMed ID: 7851026
[TBL] [Abstract][Full Text] [Related]
13. Chemoimmunotherapy in mice carrying HPV16-associated, MHC class I+ and class I- tumours: Effects of CBM-4A potentiated with IL-2, IL-12, GM-CSF and genetically modified tumour vaccines.
Indrová M; Bubeník J; Mikysková R; Mendoza L; Símová J; Bieblová J; Jandlová T; Jinoch P; Smahel M; Vonka V; Pajtasz-Piasecka E
Int J Oncol; 2003 Mar; 22(3):691-5. PubMed ID: 12579325
[TBL] [Abstract][Full Text] [Related]
14. In vivo production of interleukin-5, granulocyte-macrophage colony-stimulating factor, macrophages colony-stimulating factor, and interleukin-6 during intravenous administration of high-dose interleukin-2 in cancer patients.
Schaafsma MR; Falkenburg JH; Landegent JE; Duinkerken N; Osanto S; Ralph P; Kaushansky K; Wagemaker G; Van Damme J; Willemze R
Blood; 1991 Oct; 78(8):1981-7. PubMed ID: 1912580
[TBL] [Abstract][Full Text] [Related]
15. Induction of tumour necrosis factor receptor-expressing macrophages by interleukin-10 and macrophage colony-stimulating factor in rheumatoid arthritis.
Takasugi K; Yamamura M; Iwahashi M; Otsuka F; Yamana J; Sunahori K; Kawashima M; Yamada M; Makino H
Arthritis Res Ther; 2006; 8(4):R126. PubMed ID: 16859503
[TBL] [Abstract][Full Text] [Related]
16. Th1 cytokines are more effective than Th2 cytokines at licensing anti-tumour functions in CD40-activated human macrophages in vitro.
Luheshi N; Davies G; Poon E; Wiggins K; McCourt M; Legg J
Eur J Immunol; 2014 Jan; 44(1):162-72. PubMed ID: 24114634
[TBL] [Abstract][Full Text] [Related]
17. Gene immunotherapy in murine acute myeloid leukemia: granulocyte-macrophage colony-stimulating factor tumor cell vaccines elicit more potent antitumor immunity compared with B7 family and other cytokine vaccines.
Dunussi-Joannopoulos K; Dranoff G; Weinstein HJ; Ferrara JL; Bierer BE; Croop JM
Blood; 1998 Jan; 91(1):222-30. PubMed ID: 9414288
[TBL] [Abstract][Full Text] [Related]
18. Malaria-specific metabolite hemozoin mediates the release of several potent endogenous pyrogens (TNF, MIP-1 alpha, and MIP-1 beta) in vitro, and altered thermoregulation in vivo.
Sherry BA; Alava G; Tracey KJ; Martiney J; Cerami A; Slater AF
J Inflamm; 1995; 45(2):85-96. PubMed ID: 7583361
[TBL] [Abstract][Full Text] [Related]
19. Gender dimorphism of macrophage response to GMCSF and IL-4 for differentiation into dendritic cells.
Gupta V; Singh SM
Am J Reprod Immunol; 2008 Jul; 60(1):43-54. PubMed ID: 18593437
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-4 inhibits granulocyte-macrophage colony-stimulating factor, interleukin-6, and tumor necrosis factor-alpha expression by human monocytes in response to polymethylmethacrylate particle challenge in vitro.
Trindade MC; Nakashima Y; Lind M; Sun DH; Goodman SB; Maloney WJ; Schurman DJ; Smith RL
J Orthop Res; 1999 Nov; 17(6):797-802. PubMed ID: 10632444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
